APO Research
Talk to an analyst

APO RESEARCH · REPORT

Bio Active Protein and Peptides

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Bio Active Protein and Peptides Industry Growth and Trends Forecast to 2032

5 July 202697 pages

Choose your research edition.

Industry ResearchBio Active Protein and Peptides Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Bio Active Protein and Peptides Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Bio Active Protein and Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bio Active Protein and Peptides Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Bio Active Protein and Peptides Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Bio Active Protein and Peptides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Bio Active Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Bio Active Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bio Active Protein and Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bio Active Protein and Peptides include Archer Daniels Midland Company, Kerry Group, Cargill, Omega Protein Corporation, Bunge, DuPont, Fonterra Co-operative Group and Royal DSM, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Bio Active Protein and Peptides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Bio Active Protein and Peptides market size, estimates, and forecasts are presented in terms of sales volume (kt) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Bio Active Protein and Peptides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Bio Active Protein and Peptides.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Bio Active Protein and Peptides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Bio Active Protein and Peptides Market by Company

Archer Daniels Midland Company

Kerry Group

Cargill

Omega Protein Corporation

Bunge

DuPont

Fonterra Co-operative Group

Royal DSM

Bio Active Protein and Peptides Segment by Type

Plant Source

Animal Source

Bio Active Protein and Peptides Segment by Application

Functional Food

Functional Beverages

Dietary Supplements

Animal Nutrition

Personal Care

Others

Bio Active Protein and Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bio Active Protein and Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bio Active Protein and Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bio Active Protein and Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bio Active Protein and Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Bio Active Protein and Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Plant Source Table 2. Major Company of Animal Source Table 3. Global Bio Active Protein and Peptides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Bio Active Protein and Peptides Sales by Type (2021-2026) & (kt) Table 5. Global Bio Active Protein and Peptides Sales Market Share in Volume by Type (2021-2026) Table 6. Global Bio Active Protein and Peptides Sales by Type (2021-2026) & (US$ Million) Table 7. Global Bio Active Protein and Peptides Sales Market Share in Value by Type (2021-2026) Table 8. Global Bio Active Protein and Peptides Price by Type (2021-2026) & (USD/t) Table 9. Global Bio Active Protein and Peptides Sales by Type (2027-2032) & (kt) Table 10. Global Bio Active Protein and Peptides Sales Market Share in Volume by Type (2027-2032) Table 11. Global Bio Active Protein and Peptides Sales by Type (2027-2032) & (US$ Million) Table 12. Global Bio Active Protein and Peptides Sales Market Share in Value by Type (2027-2032) Table 13. Global Bio Active Protein and Peptides Price by Type (2027-2032) & (USD/t) Table 14. North America Bio Active Protein and Peptides Sales by Type (2021-2026) & (kt) Table 15. North America Bio Active Protein and Peptides Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Bio Active Protein and Peptides Sales by Type (2021-2026) & (kt) Table 17. Europe Bio Active Protein and Peptides Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Bio Active Protein and Peptides Sales by Type (2021-2026) & (kt) Table 19. Asia-Pacific Bio Active Protein and Peptides Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Bio Active Protein and Peptides Sales by Type (2021-2026) & (kt) Table 21. Latin America Bio Active Protein and Peptides Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Bio Active Protein and Peptides Sales by Type (2021-2026) & (kt) Table 23. Middle East and Africa Bio Active Protein and Peptides Sales by Type (2021-2026) & (US$ Million) Table 24. Bio Active Protein and Peptides Industry Trends Table 25. Bio Active Protein and Peptides Industry Drivers Table 26. Bio Active Protein and Peptides Industry Opportunities and Challenges Table 27. Bio Active Protein and Peptides Industry Restraints Table 28. Global Bio Active Protein and Peptides Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Bio Active Protein and Peptides Revenue Market Share by Company (2021-2026) Table 30. Global Bio Active Protein and Peptides Sales by Company (2021-2026) & (kt) Table 31. Global Bio Active Protein and Peptides Sales Share by Company (2021-2026) Table 32. Global Bio Active Protein and Peptides Market Price by Company (2021-2026) & (USD/t) Table 33. Global Bio Active Protein and Peptides Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Bio Active Protein and Peptides Major Company Production Sites and Headquarters Table 35. Global Bio Active Protein and Peptides Company, Product Type & Application Table 36. Global Bio Active Protein and Peptides Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Bio Active Protein and Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Bio Active Protein and Peptides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Bio Active Protein and Peptides Sales by Region (2021-2026) & (kt) Table 41. Global Bio Active Protein and Peptides Sales Market Share in Volume by Region (2021-2026) Table 42. Global Bio Active Protein and Peptides Sales by Region (2021-2026) & (US$ Million) Table 43. Global Bio Active Protein and Peptides Sales Market Share in Value by Region (2021-2026) Table 44. Global Bio Active Protein and Peptides Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 45. Global Bio Active Protein and Peptides Sales by Region (2027-2032) & (kt) Table 46. Global Bio Active Protein and Peptides Sales Market Share in Volume by Region (2027-2032) Table 47. Global Bio Active Protein and Peptides Sales by Region (2027-2032) & (US$ Million) Table 48. Global Bio Active Protein and Peptides Sales Market Share in Value by Region (2027-2032) Table 49. Global Bio Active Protein and Peptides Sales (kt), Value (US$ Million), Price (USD/t) and Gross Margin (2027-2032) Table 50. Global Bio Active Protein and Peptides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Bio Active Protein and Peptides Sales by Application (2021-2026) & (kt) Table 52. Global Bio Active Protein and Peptides Sales Market Share in Volume by Application (2021-2026) Table 53. Global Bio Active Protein and Peptides Sales by Application (2021-2026) & (US$ Million) Table 54. Global Bio Active Protein and Peptides Sales Market Share in Value by Application (2021-2026) Table 55. Global Bio Active Protein and Peptides Price by Application (2021-2026) & (USD/t) Table 56. Global Bio Active Protein and Peptides Sales by Application (2027-2032) & (kt) Table 57. Global Bio Active Protein and Peptides Sales Market Share in Volume by Application (2027-2032) Table 58. Global Bio Active Protein and Peptides Sales by Application (2027-2032) & (US$ Million) Table 59. Global Bio Active Protein and Peptides Sales Market Share in Value by Application (2027-2032) Table 60. Global Bio Active Protein and Peptides Price by Application (2027-2032) & (USD/t) Table 61. North America Bio Active Protein and Peptides Sales by Application (2021-2026) & (kt) Table 62. North America Bio Active Protein and Peptides Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Bio Active Protein and Peptides Sales by Application (2021-2026) & (kt) Table 64. Europe Bio Active Protein and Peptides Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Bio Active Protein and Peptides Sales by Application (2021-2026) & (kt) Table 66. Asia-Pacific Bio Active Protein and Peptides Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Bio Active Protein and Peptides Sales by Application (2021-2026) & (kt) Table 68. Latin America Bio Active Protein and Peptides Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Bio Active Protein and Peptides Sales by Application (2021-2026) & (kt) Table 70. Middle East and Africa Bio Active Protein and Peptides Sales by Application (2021-2026) & (US$ Million) Table 71. Archer Daniels Midland Company Company Information Table 72. Archer Daniels Midland Company Business Overview Table 73. Archer Daniels Midland Company Bio Active Protein and Peptides Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 74. Archer Daniels Midland Company Bio Active Protein and Peptides Product Portfolio Table 75. Archer Daniels Midland Company Recent Development Table 76. Kerry Group Company Information Table 77. Kerry Group Business Overview Table 78. Kerry Group Bio Active Protein and Peptides Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 79. Kerry Group Bio Active Protein and Peptides Product Portfolio Table 80. Kerry Group Recent Development Table 81. Cargill Company Information Table 82. Cargill Business Overview Table 83. Cargill Bio Active Protein and Peptides Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 84. Cargill Bio Active Protein and Peptides Product Portfolio Table 85. Cargill Recent Development Table 86. Omega Protein Corporation Company Information Table 87. Omega Protein Corporation Business Overview Table 88. Omega Protein Corporation Bio Active Protein and Peptides Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 89. Omega Protein Corporation Bio Active Protein and Peptides Product Portfolio Table 90. Omega Protein Corporation Recent Development Table 91. Bunge Company Information Table 92. Bunge Business Overview Table 93. Bunge Bio Active Protein and Peptides Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 94. Bunge Bio Active Protein and Peptides Product Portfolio Table 95. Bunge Recent Development Table 96. DuPont Company Information Table 97. DuPont Business Overview Table 98. DuPont Bio Active Protein and Peptides Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 99. DuPont Bio Active Protein and Peptides Product Portfolio Table 100. DuPont Recent Development Table 101. Fonterra Co-operative Group Company Information Table 102. Fonterra Co-operative Group Business Overview Table 103. Fonterra Co-operative Group Bio Active Protein and Peptides Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 104. Fonterra Co-operative Group Bio Active Protein and Peptides Product Portfolio Table 105. Fonterra Co-operative Group Recent Development Table 106. Royal DSM Company Information Table 107. Royal DSM Business Overview Table 108. Royal DSM Bio Active Protein and Peptides Sales (kt), Revenue (US$ Million), Price (USD/t) and Gross Margin (2021-2026) Table 109. Royal DSM Bio Active Protein and Peptides Product Portfolio Table 110. Royal DSM Recent Development Table 111. North America Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 112. North America Bio Active Protein and Peptides Sales by Country (2021-2026) & (kt) Table 113. North America Bio Active Protein and Peptides Sales Market Share by Country (2021-2026) Table 114. North America Bio Active Protein and Peptides Sales Forecast by Country (2027-2032) & (kt) Table 115. North America Bio Active Protein and Peptides Sales Market Share Forecast by Country (2027-2032) Table 116. North America Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Bio Active Protein and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Bio Active Protein and Peptides Market Share by Country (2021-2026) Table 119. North America Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Bio Active Protein and Peptides Market Share Forecast by Country (2027-2032) Table 121. Europe Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 122. Europe Bio Active Protein and Peptides Sales by Country (2021-2026) & (kt) Table 123. Europe Bio Active Protein and Peptides Sales Market Share by Country (2021-2026) Table 124. Europe Bio Active Protein and Peptides Sales Forecast by Country (2027-2032) & (kt) Table 125. Europe Bio Active Protein and Peptides Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Bio Active Protein and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Bio Active Protein and Peptides Market Share by Country (2021-2026) Table 129. Europe Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Bio Active Protein and Peptides Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Bio Active Protein and Peptides Sales by Country (2021-2026) & (kt) Table 133. Asia-Pacific Bio Active Protein and Peptides Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Bio Active Protein and Peptides Sales Forecast by Country (2027-2032) & (kt) Table 135. Asia-Pacific Bio Active Protein and Peptides Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Bio Active Protein and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Bio Active Protein and Peptides Market Share by Country (2021-2026) Table 139. Asia-Pacific Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Bio Active Protein and Peptides Market Share Forecast by Country (2027-2032) Table 141. Latin America Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 142. Latin America Bio Active Protein and Peptides Sales by Country (2021-2026) & (kt) Table 143. Latin America Bio Active Protein and Peptides Sales Market Share by Country (2021-2026) Table 144. Latin America Bio Active Protein and Peptides Sales Forecast by Country (2027-2032) & (kt) Table 145. Latin America Bio Active Protein and Peptides Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Bio Active Protein and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Bio Active Protein and Peptides Market Share by Country (2021-2026) Table 149. Latin America Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Bio Active Protein and Peptides Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (kt): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Bio Active Protein and Peptides Sales by Country (2021-2026) & (kt) Table 153. Middle East and Africa Bio Active Protein and Peptides Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Bio Active Protein and Peptides Sales Forecast by Country (2027-2032) & (kt) Table 155. Middle East and Africa Bio Active Protein and Peptides Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Bio Active Protein and Peptides Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Bio Active Protein and Peptides Market Share by Country (2021-2026) Table 159. Middle East and Africa Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Bio Active Protein and Peptides Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Bio Active Protein and Peptides Distributors List Table 164. Bio Active Protein and Peptides Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Bio Active Protein and Peptides Image Figure 2. Global Bio Active Protein and Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bio Active Protein and Peptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Bio Active Protein and Peptides Sales (2021-2032) & (kt) Figure 5. Plant Source Image Figure 6. Global Plant Source Sales YoY Growth (2021-2032) & (kt) Figure 7. Animal Source Image Figure 8. Global Animal Source Sales YoY Growth (2021-2032) & (kt) Figure 9. Global Bio Active Protein and Peptides Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Bio Active Protein and Peptides Market Share by Type 2025 VS 2032 Figure 11. North America Bio Active Protein and Peptides Sales Market Share in Volume by Type in 2025 Figure 12. North America Bio Active Protein and Peptides Sales Market Share in Value by Type in 2025 Figure 13. Europe Bio Active Protein and Peptides Sales Market Share in Volume by Type in 2025 Figure 14. Europe Bio Active Protein and Peptides Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Bio Active Protein and Peptides Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Bio Active Protein and Peptides Sales Market Share in Value by Type in 2025 Figure 17. Latin America Bio Active Protein and Peptides Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Bio Active Protein and Peptides Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Bio Active Protein and Peptides Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Bio Active Protein and Peptides Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Bio Active Protein and Peptides Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Functional Food Image Figure 24. Global Functional Food Sales YoY Growth (2021-2032) & (kt) Figure 25. Functional Beverages Image Figure 26. Global Functional Beverages Sales YoY Growth (2021-2032) & (kt) Figure 27. Dietary Supplements Image Figure 28. Global Dietary Supplements Sales YoY Growth (2021-2032) & (kt) Figure 29. Animal Nutrition Image Figure 30. Global Animal Nutrition Sales YoY Growth (2021-2032) & (kt) Figure 31. Personal Care Image Figure 32. Global Personal Care Sales YoY Growth (2021-2032) & (kt) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (kt) Figure 35. Global Bio Active Protein and Peptides Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Bio Active Protein and Peptides Market Share by Application 2025 VS 2032 Figure 37. North America Bio Active Protein and Peptides Sales Market Share in Volume by Application in 2025 Figure 38. North America Bio Active Protein and Peptides Sales Market Share in Value by Application in 2025 Figure 39. Europe Bio Active Protein and Peptides Sales Market Share in Volume by Application in 2025 Figure 40. Europe Bio Active Protein and Peptides Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Bio Active Protein and Peptides Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Bio Active Protein and Peptides Sales Market Share in Value by Application in 2025 Figure 43. Latin America Bio Active Protein and Peptides Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Bio Active Protein and Peptides Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Bio Active Protein and Peptides Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Bio Active Protein and Peptides Sales Market Share in Value by Application in 2025 Figure 47. North America Bio Active Protein and Peptides Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 48. North America Bio Active Protein and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Bio Active Protein and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Bio Active Protein and Peptides Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 52. Europe Bio Active Protein and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Bio Active Protein and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Bio Active Protein and Peptides Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 56. Asia-Pacific Bio Active Protein and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Bio Active Protein and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Bio Active Protein and Peptides Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 60. Latin America Bio Active Protein and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Bio Active Protein and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Bio Active Protein and Peptides Sales by Country: 2021 VS 2025 VS 2032 (kt) Figure 64. Middle East and Africa Bio Active Protein and Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Bio Active Protein and Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Bio Active Protein and Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Bio Active Protein and Peptides Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Bio Active Protein and Peptides Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Plant Source
  • Animal Source
Applications
  • Functional Food
  • Functional Beverages
  • Dietary Supplements
  • Animal Nutrition
  • Personal Care
  • Others
Companies covered
  • Archer Daniels Midland Company
  • Kerry Group
  • Cargill
  • Omega Protein Corporation
  • Bunge
  • DuPont
  • Fonterra Co-operative Group
  • Royal DSM

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Bio Active Protein and Peptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Bio Active Protein and Peptides Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Bio Active Protein and Peptides Market by Type
  6. 1.3.1 Plant Source
  7. 1.3.2 Animal Source
  8. 1.4 Global Bio Active Protein and Peptides Market Size by Type
  9. 1.4.1 Global Bio Active Protein and Peptides Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Bio Active Protein and Peptides Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Bio Active Protein and Peptides Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Bio Active Protein and Peptides Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Bio Active Protein and Peptides Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Bio Active Protein and Peptides Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Bio Active Protein and Peptides Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Bio Active Protein and Peptides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Bio Active Protein and Peptides Industry Trends
  2. 2.2 Bio Active Protein and Peptides Industry Drivers
  3. 2.3 Bio Active Protein and Peptides Industry Opportunities and Challenges
  4. 2.4 Bio Active Protein and Peptides Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Bio Active Protein and Peptides Revenue (2021-2026)
  2. 3.2 Global Top Players by Bio Active Protein and Peptides Sales (2021-2026)
  3. 3.3 Global Top Players by Bio Active Protein and Peptides Price (2021-2026)
  4. 3.4 Global Bio Active Protein and Peptides Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bio Active Protein and Peptides Major Company Production Sites & Headquarters
  6. 3.6 Global Bio Active Protein and Peptides Company, Product Type & Application
  7. 3.7 Global Bio Active Protein and Peptides Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bio Active Protein and Peptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bio Active Protein and Peptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bio Active Protein and Peptides Tier 1, Tier 2, and Tier 3
4 Bio Active Protein and Peptides Regional Status and Outlook
  1. 4.1 Global Bio Active Protein and Peptides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Bio Active Protein and Peptides Historic Market Size by Region
  3. 4.2.1 Global Bio Active Protein and Peptides Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Bio Active Protein and Peptides Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Bio Active Protein and Peptides Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Bio Active Protein and Peptides Forecasted Market Size by Region
  7. 4.3.1 Global Bio Active Protein and Peptides Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Bio Active Protein and Peptides Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Bio Active Protein and Peptides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Bio Active Protein and Peptides by Application
  1. 5.1 Bio Active Protein and Peptides Market by Application
  2. 5.1.1 Functional Food
  3. 5.1.2 Functional Beverages
  4. 5.1.3 Dietary Supplements
  5. 5.1.4 Animal Nutrition
  6. 5.1.5 Personal Care
  7. 5.1.6 Others
  8. 5.2 Global Bio Active Protein and Peptides Market Size by Application
  9. 5.2.1 Global Bio Active Protein and Peptides Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Bio Active Protein and Peptides Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Bio Active Protein and Peptides Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Bio Active Protein and Peptides Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Bio Active Protein and Peptides Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Bio Active Protein and Peptides Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Bio Active Protein and Peptides Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Bio Active Protein and Peptides Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Archer Daniels Midland Company
  2. 6.1.1 Archer Daniels Midland Company Company Information
  3. 6.1.2 Archer Daniels Midland Company Business Overview
  4. 6.1.3 Archer Daniels Midland Company Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Archer Daniels Midland Company Bio Active Protein and Peptides Product Portfolio
  6. 6.1.5 Archer Daniels Midland Company Recent Developments
  7. 6.2 Kerry Group
  8. 6.2.1 Kerry Group Company Information
  9. 6.2.2 Kerry Group Business Overview
  10. 6.2.3 Kerry Group Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Kerry Group Bio Active Protein and Peptides Product Portfolio
  12. 6.2.5 Kerry Group Recent Developments
  13. 6.3 Cargill
  14. 6.3.1 Cargill Company Information
  15. 6.3.2 Cargill Business Overview
  16. 6.3.3 Cargill Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Cargill Bio Active Protein and Peptides Product Portfolio
  18. 6.3.5 Cargill Recent Developments
  19. 6.4 Omega Protein Corporation
  20. 6.4.1 Omega Protein Corporation Company Information
  21. 6.4.2 Omega Protein Corporation Business Overview
  22. 6.4.3 Omega Protein Corporation Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Omega Protein Corporation Bio Active Protein and Peptides Product Portfolio
  24. 6.4.5 Omega Protein Corporation Recent Developments
  25. 6.5 Bunge
  26. 6.5.1 Bunge Company Information
  27. 6.5.2 Bunge Business Overview
  28. 6.5.3 Bunge Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bunge Bio Active Protein and Peptides Product Portfolio
  30. 6.5.5 Bunge Recent Developments
  31. 6.6 DuPont
  32. 6.6.1 DuPont Company Information
  33. 6.6.2 DuPont Business Overview
  34. 6.6.3 DuPont Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 DuPont Bio Active Protein and Peptides Product Portfolio
  36. 6.6.5 DuPont Recent Developments
  37. 6.7 Fonterra Co-operative Group
  38. 6.7.1 Fonterra Co-operative Group Company Information
  39. 6.7.2 Fonterra Co-operative Group Business Overview
  40. 6.7.3 Fonterra Co-operative Group Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Fonterra Co-operative Group Bio Active Protein and Peptides Product Portfolio
  42. 6.7.5 Fonterra Co-operative Group Recent Developments
  43. 6.8 Royal DSM
  44. 6.8.1 Royal DSM Company Information
  45. 6.8.2 Royal DSM Business Overview
  46. 6.8.3 Royal DSM Bio Active Protein and Peptides Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Royal DSM Bio Active Protein and Peptides Product Portfolio
  48. 6.8.5 Royal DSM Recent Developments
7 North America by Country
  1. 7.1 North America Bio Active Protein and Peptides Sales by Country
  2. 7.1.1 North America Bio Active Protein and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Bio Active Protein and Peptides Sales by Country (2021-2026)
  4. 7.1.3 North America Bio Active Protein and Peptides Sales Forecast by Country (2027-2032)
  5. 7.2 North America Bio Active Protein and Peptides Market Size by Country
  6. 7.2.1 North America Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Bio Active Protein and Peptides Market Size by Country (2021-2026)
  8. 7.2.3 North America Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Bio Active Protein and Peptides Sales by Country
  2. 8.1.1 Europe Bio Active Protein and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Bio Active Protein and Peptides Sales by Country (2021-2026)
  4. 8.1.3 Europe Bio Active Protein and Peptides Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Bio Active Protein and Peptides Market Size by Country
  6. 8.2.1 Europe Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Bio Active Protein and Peptides Market Size by Country (2021-2026)
  8. 8.2.3 Europe Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Bio Active Protein and Peptides Sales by Country
  2. 9.1.1 Asia-Pacific Bio Active Protein and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Bio Active Protein and Peptides Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Bio Active Protein and Peptides Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Bio Active Protein and Peptides Market Size by Country
  6. 9.2.1 Asia-Pacific Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Bio Active Protein and Peptides Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Bio Active Protein and Peptides Sales by Country
  2. 10.1.1 South America Bio Active Protein and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Bio Active Protein and Peptides Sales by Country (2021-2026)
  4. 10.1.3 South America Bio Active Protein and Peptides Sales Forecast by Country (2027-2032)
  5. 10.2 South America Bio Active Protein and Peptides Market Size by Country
  6. 10.2.1 South America Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Bio Active Protein and Peptides Market Size by Country (2021-2026)
  8. 10.2.3 South America Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Bio Active Protein and Peptides Sales by Country
  2. 11.1.1 Middle East and Africa Bio Active Protein and Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Bio Active Protein and Peptides Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Bio Active Protein and Peptides Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Bio Active Protein and Peptides Market Size by Country
  6. 11.2.1 Middle East and Africa Bio Active Protein and Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Bio Active Protein and Peptides Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Bio Active Protein and Peptides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Bio Active Protein and Peptides Value Chain Analysis
  2. 12.1.1 Bio Active Protein and Peptides Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Bio Active Protein and Peptides Production Mode & Process
  7. 12.2 Bio Active Protein and Peptides Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Bio Active Protein and Peptides Distributors
  10. 12.2.3 Bio Active Protein and Peptides Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst